{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:55:10Z","timestamp":1766811310784,"version":"3.48.0"},"reference-count":3,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025]]},"DOI":"10.3960\/jslrt.25084","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T22:08:31Z","timestamp":1766527711000},"page":"223-224","source":"Crossref","is-referenced-by-count":0,"title":["Highlights: Immunotherapy for B-cell lymphoma"],"prefix":"10.3960","volume":"65","author":[{"given":"Kana","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Mie University Graduate                            School of Medicine, Tsu, Mie, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Westin                            JR,                                Oluwole                            OO,                                Kersten                            MJ                    <i>et al.<\/i> Survival with Axicabtagene Ciloleucel in Large B-Cell                    Lymphoma. N Engl J Med. 2023; 389: 148-157.","DOI":"10.1056\/NEJMoa2301665"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Abramson                            JS,                                Solomon                            SR,                                Arnason                            J                    <i>et al.<\/i> Lisocabtagene maraleucel as second-line therapy for                    large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study. Blood.                    2023; 141: 1675-1684.","DOI":"10.1182\/blood.2022018730"},{"key":"3","unstructured":"3 Suzuki                            T,                                Iida                            S. Advances and                    future perspectives in chimeric antigen receptor T-cell and bispecific antibody                    therapies for multiple myeloma. J Clin Exp Hematop.; in press."}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25084\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:41:53Z","timestamp":1766810513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/4\/65_25084\/_article"}},"subtitle":["Recent advances in immunotherapy for B-cell lymphoma"],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25084","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"type":"print","value":"1346-4280"},{"type":"electronic","value":"1880-9952"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25084"}}